VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
NHI
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
NHINational Health Investors, Inc.
$77.49$3.8B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders

NHI logoNational Health Investors, Inc.(NHI)Earnings, Financials & Key Ratios

NHI•NYSE•REIT / Real Estate
$76.55
25.3× P/E·Price updated Jul 2, 2026
SectorReal EstateIndustryHealthcare REITsSub-IndustrySenior housing and skilled nursing
AboutIncorporated in 1991, National Health Investors, Inc. (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.Show more
  • Revenue$379M+12.9%
  • FFO$226M+7.9%
  • FFO/Share4.80+1.2%
  • FFO Payout75.08%+0.5%
  • FFO per Share4.80+1.2%
  • NOI Margin36.7%-62.0%
  • FFO Margin59.71%-4.4%
  • ROE9.72%-6.3%
  • ROA5.25%-2.8%

NHI Price & Volume

National Health Investors, Inc. (NHI) stock price & volume — 10-year historical chart

Loading chart...

Strategic SHOP Transition Drives Revenue Growth Volatility

Investment Thesis • Updated 2026Q1

VerdictNeutral
Growth:Accelerating
Profitability:Moderate
Financial:Healthy
Cash Flow:Robust
Primary Risk:SHOP transition operational volatility

Key Thesis Takeaways

  • National Health Investors is undergoing a fundamental transformation as it pivots toward operationally intensive SHOP assets, which has catalyzed a 29.7% revenue surge in 2026Q1 but simultaneously compressed NOI margins to 31.1%.
  • While the company’s aggressive deleveraging to zero total debt provides significant balance sheet flexibility, investors should monitor whether this operational complexity creates long-term margin pressure.
  • The sustainability of the current dividend, supported by a 0.69 AFFO payout ratio, remains a key focal point as the firm navigates the capital-intensive requirements of its evolving portfolio.

Verdict Logic

while the elimination of $1.2 billion in debt is a positive signal, the compression of NOI margins to 31.1% suggests that the ongoing transition to SHOP assets may introduce operational volatility that warrants further observation.

NHI Growth Metrics

National Health Investors, Inc. (NHI) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years5.15%
5 Years2.61%
3 Years10.81%
TTM17.48%

Profit CAGR

10 Years-0.46%
5 Years-5.14%
3 Years28.89%
TTM4.89%

EPS CAGR

10 Years-2.65%
5 Years-0.07%
3 Years80.92%
TTM-1.59%

Return on Capital

10 Years7.53%
5 Years7.16%
3 Years8.09%
Last Year8%

NHI Recent Earnings

National Health Investors, Inc. (NHI) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 10/12 qtrs (83%)●Beat Revenue 9/12 qtrs (75%)
Q2 2026Latest
May 4, 2026
Metric
Actual
Est
EPS
$1.24+2.5%
$1.21
Rev
$73M+4.2%
$70M
Q1 2026
Feb 26, 2026
Metric
Actual
Est
EPS
$1.22+52.3%
$0.80
Rev
$70M+1.8%
$69M
Q4 2025
Nov 6, 2025
Metric
Actual
Est
EPS
$1.32+6.5%
$1.24
Rev
$90M-5.5%
$95M
Q3 2025
Aug 6, 2025
Metric
Actual
Est
EPS
$1.22+5.2%
$1.16
Rev
$91M+6.7%
$86M
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestMay 4, 2026
$1.24vs $1.21+2.5%
$73Mvs $70M+4.2%
Q1 2026Feb 26, 2026
$1.22vs $0.80+52.3%
$70Mvs $69M+1.8%
Q4 2025Nov 6, 2025
$1.32vs $1.24+6.5%
$90Mvs $95M-5.5%
Q3 2025Aug 6, 2025
$1.22vs $1.16+5.2%
$91Mvs $86M+6.7%
Based on last 12 quarters of dataView full earnings history →

Latest NHI News

Recent stock market news and headlines for National Health Investors, Inc. (NHI)

Zacks Investment Research·Jun 26, 2026
SHO vs. NHI: Which Stock Is the Better Value Option?

Investors interested in REIT and Equity Trust - Other stocks are likely familiar with Sunstone Hotel Investors (SHO) and National Health Investors (NHI). But which of these two stocks offers value investors a better bang for their buck right now?

Seeking Alpha·Jun 24, 2026
National Health Investors: The Silver Tsunami Makes This REIT Undervalued

National Health Investors, Inc. remains a Buy, supported by strong financials, an attractive valuation, and a sustainable ~5% dividend yield. NHI's $560M asset sale and $107M SHOP investment accelerate its transition to the Senior Housing Operating Portfolio model, enhancing growth potential. Pro forma net debt/EBITDA expected at 2.3x following NHI's major sale and a ~74.5% FAD payout ratio based on guidance highlight NHI's balance sheet strength and dividend flexibility.

PRNewsWire·Jun 23, 2026
Honeywell Aerospace Set to Join S&P 500 & S&P 100; Others to Join S&P MidCap 400 and S&P SmallCap 600

NEW YORK, June 23, 2026 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P 500, S&P 100, S&P MidCap 400, and S&P SmallCap 600:  Honeywell Aerospace Inc. (NASD: HONA) will be added to the S&P 500 & 100 on Monday, June 29. Honeywell Aerospace will replace Conagra Brands Inc. (NYSE: CAG) in the S&P 500, and Conagra Brands will replace Grid Dynamics Holdings Inc.(NASD: GDYN) in the S&P SmallCap 600 effective prior to the opening of trading on Tuesday, June 30.

Peers Comparison

Key metrics vs top competitors for National Health Investors, Inc. (NHI)

Full Screener →
CompanyPriceMarket CapP/E RatioRev Growth (1Y)Net MarginROEDiv Yield
NHI logoNHINational Health Investors, Inc.Current
$76.55$3.71B25.3512.93%37.56%9.72%4.71%
OHI logoOHIOmega Healthcare Investors, Inc.
$48.17$14.35B24.8313.95%51.02%11.85%—
SBRA logoSBRASabra Health Care REIT, Inc.
$19.68$4.96B30.7510.15%19.21%5.6%—
LTC logoLTCLTC Properties, Inc.
$38.85$1.99B15.4225.26%39.08%10.9%—
CTRE logoCTRECareTrust REIT, Inc.
$40.90$9.66B26.05108.79%71.55%8.63%—
GMRE logoGMREGlobal Medical REIT Inc.
$35.74$94.26M115.297.08%-8.18%-2.31%—

Compare NHI vs Peers

National Health Investors, Inc. (NHI) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs OHI

Most directly comparable listed peer for NHI.

Scale Benchmark

vs WELL

Larger-name benchmark to compare NHI against a more recognizable public peer.

Peer Set

Compare Top 5

vs OHI, SBRA, LTC, CTRE

NHI SEC Filings & Documents

National Health Investors, Inc. (NHI) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

May 4, 2026·SEC

Material company update

May 4, 2026·SEC

Material company update

May 4, 2026·SEC

10-K Annual Reports

2
FY 2026

Feb 26, 2026·SEC

FY 2025

Feb 25, 2025·SEC

10-Q Quarterly Reports

5
FY 2026

May 4, 2026·SEC

FY 2025

Nov 6, 2025·SEC

FY 2025

Aug 6, 2025·SEC

Get notified when NHI posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

NHI Frequently Asked Questions

National Health Investors, Inc. (NHI) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials
What is National Health Investors, Inc.'s revenue?

National Health Investors, Inc. (NHI) reported $402.9M in revenue for fiscal year 2025. This represents a 305% increase from $99.4M in 1996.

How fast is National Health Investors, Inc. growing?

National Health Investors, Inc. (NHI) grew revenue by 12.9% over the past year. This is steady growth.

Is NHI profitable?

Yes, National Health Investors, Inc. (NHI) is profitable, generating $148.1M in net income for fiscal year 2025 (37.6% net margin).

Dividend & Returns
Does NHI pay dividends?

Yes, National Health Investors, Inc. (NHI) pays a dividend with a yield of 4.71%. This makes it attractive for income-focused investors.

What is NHI's return on equity?

National Health Investors, Inc. (NHI) has a return on equity (ROE) of 9.7%. This is below average, suggesting room for improvement.

Industry Metrics
What is National Health Investors, Inc.'s FFO?

National Health Investors, Inc. (NHI) generated Funds From Operations (FFO) of $235.0M in the trailing twelve months. FFO is the primary profitability metric for REITs.

Is NHI a good dividend stock?

National Health Investors, Inc. (NHI) offers a 4.71% dividend yield, which is attractive for income investors. REITs are required to distribute at least 90% of taxable income to shareholders.

What if you invested $1,000 in NHI back in 1996?

Total return calculator · dividends reinvested · 30+ years of data

See returns →